You have read all your free articles, to continue reading subscribe to read the rest of this content.
Spago Nanomedical has received notice from the United States Patent and Trademark Office (USPTO) that it intends to grant the company’s patent application including a critical component of the SpagoPix candidate drug SN132D. The patent will be granted following confirmation of Spago NanomedicalAlready a subscriber Login You have read all…
The US patent and trademark office has issued a notice that they intend to grant additional patents to Oncopeptides AB in the US. These patents protect, inter alia, the freeze-dried formulation. The patent protection extends to 2033. The freeze-dried preparation with melflufen is intended to be mAlready a subscriber Login…
On October 1st, seven EU member states signed the Protocol on the Provisional Application of the Agreement on the Unified Patent Court. In addition, a number of other states affirmed their support and are expected to sign the protocol soon. The protocol is another milestone towards the realizatioAlready a subscriber…
BioInvent International announces that it has been granted additional patent protection in Japan, Russia and China for BI-505, its lead immune-oncology programme currently in Phase II for the treatment of multiple myeloma. These patents cover the use of BI-505 in the treatment of patients previouAlready a subscriber Login You have…
